The investigation arose from the analysis of blood samples collected from 137 adolescents enrolled in the Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS), the largest longitudinal study of pediatric bariatric surgery in the United States. Researchers identified that those adolescents exhibiting blood PFHpA concentrations twice as high as their counterparts faced an 80% greater probability of being diagnosed with MASLD. Moreover, these individuals demonstrated more advanced pathological hallmarks, including hepatic inflammation and fibrosis, which are established precursors to cirrhosis, liver failure, and hepatocellular carcinoma. This clinical association was substantiated through meticulous laboratory experiments employing PFHpA doses commensurate with real-world human exposure levels. Using 3D liver spheroids cultivated under controlled conditions, the team delineated how PFHpA disrupts critical biological pathways involving inflammatory signaling cascades, oxidative stress induction, and aberrant lipid metabolism, all converging to propagate hepatic injury. The synergy of patient-derived clinical data with rigorous in vitro modeling enabled the characterization of a unique molecular signature emblematic of PFHpA-mediated hepatotoxicity.

Metabolic dysfunction-associated steatotic liver disease, previously recognized as non-alcoholic fatty liver disease (NAFLD), remains one of the most prevalent hepatic conditions in children and adolescents nationwide, affecting about five to ten percent of this population and exceeding 30% prevalence among those with obesity. Alarmingly, MASLD incidence is climbing, portending severe complications such as type 2 diabetes mellitus and cardiovascular pathology. The identification of PFHpA as a contributory environmental factor exacerbating MASLD progression carries profound implications, especially given the ubiquitous presence of PFAS substances. Owing to their widespread use in consumer goods like food packaging, waterproof apparel, cosmetics, and non-stick cookware, PFAS contamination extends across numerous water supplies throughout the United States. Recent estimates indicate nearly half of all American municipal water systems contain measurable PFAS concentrations, underscoring the pressing public health challenge.

Dr. Lida Chatzi, MD, PhD, the study’s senior investigator and director of the ShARP Center, emphasized the significance of these findings, noting that “PFHpA, despite being less notorious than legacy PFAS such as PFOA and PFOS, likely poses comparable risks to human health.” Her call to action stresses the imperative for comprehensive regulatory frameworks that encompass emerging PFAS compounds alongside well-characterized legacy chemicals. This holistic regulatory approach is necessary to mitigate community exposures that continue unabated amid evolving chemical production landscapes.

The study’s translational framework exemplifies a robust integration of epidemiology and bench science. Brittney O. Baumert, PhD, MPH, lead author and postdoctoral fellow at USC, highlighted that “our research transcends correlative analyses, leveraging translational methodologies to elucidate the cellular and molecular perturbations induced by PFAS exposure.” By bridging clinical phenotypes with mechanistic data, the team aims to empower precision environmental health efforts that can identify and shield vulnerable groups—especially children and adolescents who bear heightened susceptibilities during critical windows of development.

Complementing this work, co-investigator Ana C. Maretti-Mira, PhD, led the in vitro studies that mapped PFAS activation of intracellular pathways within liver cells. “Decoding these pathways permits the identification of potential therapeutic targets to intervene before PFAS-related liver disease reaches irreversible stages,” she explained. This approach not only advances mechanistic understandings but also opens avenues for clinical interventions aimed at interrupting the progression from early hepatic injury to chronic liver disease.

Embedded within the broader mission of the USC Superfund Research Program, funded by the National Institute of Environmental Health Sciences (NIEHS), this research exemplifies a commitment to deciphering the health impacts of hazardous chemical exposures and translating findings into actionable prevention and policy. The USC team employed state-of-the-art exposomics technologies, including untargeted metabolomics, proteomics, and single-cell transcriptomics, to precisely characterize the molecular footprints of PFHpA exposure. Such sophisticated methodologies enable unprecedented resolution in linking environmental exposures to health outcomes, fostering a new era of precision environmental medicine.

Looking forward, the ShARP Center aims to extend its research to real-world community settings, focusing on the reduction of PFAS exposures through innovative engineering solutions and enhanced public engagement. Efforts will include the development of advanced PFAS remediation technologies, community education initiatives to raise awareness and behavioral modifications, as well as training programs to cultivate the next generation of environmental health scientists and engineers. These comprehensive strategies are integral to advancing precision health paradigms, where interventions can be tailored to individual risk profiles and environmental contexts to more effectively prevent chemical-mediated diseases.

The multi-institutional research team assembled for this study includes experts spanning the University of Southern California, Emory University, Barcelona Institute for Global Health, University of Rhode Island, Mount Sinai Icahn School of Medicine, University of California campuses, Northwestern University, Cincinnati Children’s Hospital Medical Center, Baylor College of Medicine, the National Cancer Institute, Children’s Hospital Los Angeles, and others. This collaborative network underscores the complexity of unraveling environmental health challenges and the necessity of cross-disciplinary expertise.

Funding sources supporting this work encompass a broad sweep of national and international agencies, reflecting the global urgency of addressing PFAS contamination and its health ramifications. These include the NIEHS, the National Institutes of Health (NIH), European Union exposome initiatives such as ATHLETE, California Environmental Protection Agency, and the U.S. Department of Agriculture. The diverse financial backing enables comprehensive research from molecular mechanistic studies to community-engaged interventions, fostering translational impact.

Conflict of interest disclosures reveal that while most authors report no conflicts, a few have consultancy relationships or advisory roles with pharmaceutical companies unrelated to this study, ensuring transparency. Notably, Dr. Bartell and Dr. Chatzi have provided expert assistance in legal cases involving PFAS exposures, reflecting their recognized expertise in this arena.

This landmark study fundamentally shifts our understanding of how lesser-known PFAS compounds like PFHpA contribute to childhood liver disease, a condition with rapidly escalating prevalence and severe long-term consequences. By illuminating molecular mechanisms and championing comprehensive research-to-policy pathways, it paves the way for targeted interventions to safeguard vulnerable youth globally, addressing a critical public health crisis with precision and urgency.

Subject of Research: Lab-produced tissue samples

Article Title: Translational Framework Linking Perfluoroheptanoic Acid (PFHpA) Exposure to Metabolic Dysfunction Associated Steatotic Liver Disease in Adolescents

News Publication Date: 29-Oct-2025

Web References:

• Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and Prevention (ShARP) Center: https://sharpcenter.usc.edu/
• Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study: https://www.niddk.nih.gov/about-niddk/research-areas/obesity/bariatric-surgery-teens-severe-obesity-study-teen-labs
• Communications Medicine article DOI: http://dx.doi.org/10.1038/s43856-025-01168-z

References:
The original peer-reviewed publication in Communications Medicine (Nature Portfolio), along with cited funding grants and participating institutions detailed in the research disclosure.

Keywords: Liver damage, Fatty liver disease, Steatohepatitis, Liver cancer, Chemical pollution, Water pollution, Pollutants, Inflammation, Oxidative stress, Lipid metabolism

Since its inception in 2008, the Childhood Obesity Conference has been a benchmark meeting for clinicians, researchers, public health officials, and community advocates devoted to unpacking the complex etiologies and interventions of pediatric obesity. Over nearly two decades, the conference has evolved into a pivotal forum for exchanging cutting-edge research findings and clinical best practices. The 2025 edition, embraced by the theme “Be the Reason Kids Greaux Healthy,” intensifies focus on amplifying Louisiana’s efforts in combating childhood obesity—an epidemic deeply intertwined with metabolic dysfunction and socio-environmental determinants of health.

The pathogenesis of childhood obesity is multifactorial, encompassing genetic predispositions, nutritional imbalances, sedentary lifestyles, and psychosocial stressors. Pennington Biomedical’s longstanding research excellence enables this conference to serve as a conduit for disseminating the latest evidence-based strategies, including precision nutrition approaches, metabolic profiling techniques, and pediatric exercise interventions. Dr. John Kirwan, Executive Director of Pennington Biomedical, emphasizes the conference’s critical role in uniting various healthcare providers to foster innovation and promote sustainable health outcomes for children at risk of obesity-related complications.

An integral component of the conference is the opportunity to earn up to 7.5 Continuing Medical Education (CME) credits, ensuring that pediatricians, dietitians, nurses, social workers, and allied health professionals receive formal recognition for their engagement. The full-day event awards 4 CMEs, with an additional 3.5 available through the Motivational Interviewing pre-conference session, which focuses on enhancing clinician-patient rapport through evidence-supported communication methodologies. This workshop addresses the behavioral components crucial in obesity management, teaching attendees to effectively elicit patient motivation and facilitate health behavior modifications.

Childhood obesity is intricately linked to overarching metabolic disorders, including insulin resistance, type 2 diabetes mellitus, dyslipidemia, and hypertension. Pennington Biomedical’s mission aligns with elucidating these pathophysiological processes through rigorous basic, clinical, and population-based studies. By translating this extensive body of research to practical clinical settings, the conference fosters the integration of metabolic health insights into pediatric care protocols. This translational approach is vital for developing preventative frameworks that consider both biological mechanisms and environmental modifiers.

Community engagement remains a cornerstone of the Greaux Healthy initiative and the 2025 conference. Beyond healthcare practitioners, the event actively encourages participation from policymakers, educators, nonprofit leaders, and advocates who influence childhood health determinants at the systemic level. This inclusive strategy reflects an understanding that addressing childhood obesity extends beyond clinical management to encompass educational programs, food policy reforms, urban planning for physical activity, and social support networks tailored for children and families.

Technical advancements in research facilities and scientific infrastructure significantly bolster the event’s impact. Pennington Biomedical’s extensive network of 44 clinics, 16 specialized core service facilities, and a scientific workforce exceeding 600 employees epitomizes a state-of-the-art research environment. Cutting-edge technologies such as high-throughput metabolomics, genetic sequencing, and advanced imaging modalities enhance the ability to characterize obesity phenotypes and metabolic derangements in pediatric populations. The conference serves as a platform to showcase these innovations and foster collaborative research endeavors.

Furthermore, the conference underscores the need for comprehensive education programs targeting various stakeholders involved in pediatric health. The inclusion of sessions on science communication, educational institution roles, and strategies to engage high school students reflects a commitment to fostering early awareness and prevention. By equipping educators and health communicators with accurate, accessible knowledge, the conference aims to bridge the gap between scientific discovery and community implementation, ultimately empowering children and families to make informed health decisions.

The dynamic interface of metabolic disorders, such as obesity and diabetes, with demographic factors like age group and social determinants highlights the complexity of childhood obesity as a public health concern. This intersectionality is reflected in the plenary sessions and panel discussions, which examine topics ranging from epidemiological trends among infants, children, and adolescents to culturally sensitive intervention approaches. The conference’s multidisciplinary nature facilitates an integrative understanding necessary for devising targeted, effective prevention and treatment programs.

In the clinical research realm, participants are introduced to novel therapeutic avenues rooted in molecular biology and metabolic regulation. These include gut microbiome modulation, hormone analog treatments, and nutrigenomics, all of which promise personalized medicine applications in the fight against pediatric obesity. The conference promotes dialogue on the translational potential and ethical considerations of these emerging interventions, fostering informed clinical decision-making grounded in rigorous scientific validation.

Pennington Biomedical’s leadership in metabolic disease research positions the conference as a global nexus for pioneering scientific exchange. By spotlighting recent peer-reviewed studies and presenting longitudinal cohort data, the event sets a benchmark for evidence-based practices. The collaborative atmosphere propels advancements that transcend academic walls, resulting in tangible health policy recommendations and improved pediatric care standards at regional and national levels.

Ultimately, the 2025 Childhood Obesity Conference epitomizes a concerted effort to dismantle the complex network of biological, behavioral, and environmental factors driving childhood obesity. By integrating high-level scientific insight with pragmatic clinical tools and community-oriented strategies, the event aspires to catalyze a paradigm shift in how childhood metabolic health is addressed. The conference’s impact resonates beyond Louisiana, offering a replicable model for other regions grappling with similar public health challenges.

In conclusion, this forthcoming conference embodies Pennington Biomedical Research Center’s unwavering commitment to translating scientific discovery into actionable solutions that foster healthier generations. Through multifaceted engagement, advanced education, and innovative research dissemination, the “Be the Reason Kids Greaux Healthy” initiative fortifies the fight against childhood obesity—a battle integral to securing lifelong metabolic wellness and societal prosperity.

Subject of Research: Childhood Obesity, Metabolic Disorders, Pediatric Health, Behavior-Change Counseling, Public Health Intervention

Article Title: Pennington Biomedical to Host 2025 Childhood Obesity Conference: Advancing Science and Community Engagement to Combat Pediatric Obesity

News Publication Date: Information not provided

Web References:

• Pennington Biomedical Research Center
• 2025 Childhood Obesity Conference Registration

Image Credits: PBRC

Keywords: Childhood obesity, Obesity, Metabolic disorders, Diabetes, Children, Infants, Young people, Scientific facilities, Science communication, Research programs, Education, Educational facilities, Educational institutions, Educational programs, Science education, Students, High school students